Drug and device makers confront Trump tariffs

By Axios
| April 03, 2025

A day after deep FDA cuts rocked their world, drug and med tech companies faced another potentially big hit when President Trump announced a baseline 10% tariff on U.S. imports.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...